<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01439880</url>
  </required_header>
  <id_info>
    <org_study_id>20110110</org_study_id>
    <secondary_id>2011-001915-29</secondary_id>
    <nct_id>NCT01439880</nct_id>
  </id_info>
  <brief_title>Open Label Study of Long Term Evaluation Against LDL-C Trial</brief_title>
  <acronym>OSLER</acronym>
  <official_title>A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 (Evolocumab)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amgen</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amgen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary clinical hypothesis is that long-term exposure of evolocumab (AMG 145) will be
      safe and well tolerated in adults with hypercholesterolemia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 7, 2011</start_date>
  <completion_date type="Actual">June 20, 2018</completion_date>
  <primary_completion_date type="Actual">June 20, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Adverse Events</measure>
    <time_frame>52 weeks in the SOC-controlled period and up to 4 years in the All-IP period; actual median duration of treatment in the All-IP period was 46.9 months.</time_frame>
    <description>Adverse event (AE) severity assessments were made using National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) grading, version 4.03, where grade 1 = mild AE, grade 2 = moderate AE, Grade 3 = severe AE, grade 4 = life-threatening AE and Grade 5 = death due to AE.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Low-density Lipoprotein Cholesterol (LDL-C) Level at Week 24 and Week 52</measure>
    <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-high-density Lipoprotein Cholesterol (Non-HDL-C) Level at Week 24 and Week 52</measure>
    <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apolipoprotein B Level at Week 24 and Week 52</measure>
    <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol/HDL-C Ratio at Week 24 and Week 52</measure>
    <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apolipoprotein B/Apolipoprotein A1 Ratio at Week 24 and Week 52</measure>
    <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1324</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants received standard of care (SOC) treatment for the first year of the study (SOC-controlled period). At week 52 participants began treatment with evolocumab 420 mg once a month (QM) for 4 years during the all-investigational product [all-IP] period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Evolocumab + SOC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received evolocumab 420 mg once a month plus standard of care for the first year of the study (SOC-controlled period). At week 52 participants continued treatment with evolocumab 420 mg QM for another 4 years during the all-IP period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Evolocumab</intervention_name>
    <description>Administered by subcutaneous injection</description>
    <arm_group_label>Evolocumab + SOC</arm_group_label>
    <arm_group_label>Standard of Care</arm_group_label>
    <other_name>AMG 145</other_name>
    <other_name>Repatha</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Standard of care therapy as per local practices. This could include prescribed therapies and/or dietary/exercise regimes</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Complete a qualifying evolocumab (AMG 145) parent study protocol, including: 20101154
             (NCT01375777), 20101155 (NCT01380730), 20090158 (NCT01375751), 20090159 (NCT01375764),
             and 20110231 (NCT01652703)

        Exclusion Criteria:

          -  Experienced a treatment-related serious adverse event that led to investigational
             product (IP) discontinuation in the parent study

          -  Have an unstable medical condition, in the judgment of the investigator

          -  Known sensitivity to any of the products to be administered during dosing

          -  Currently enrolled in another investigational device or drug study (excluding
             evolocumab (AMG 145) parent study), or less than 30 days since ending another
             investigational device or drug study(s),or receiving other investigational agent(s)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MD</last_name>
    <role>Study Director</role>
    <affiliation>Amgen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Malvern</city>
        <state>Arkansas</state>
        <zip>72104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <zip>95608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Inglewood</city>
        <state>California</state>
        <zip>90301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <zip>92780</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <zip>80120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Green Cove Springs</city>
        <state>Florida</state>
        <zip>32043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32223</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ponte Vedra</city>
        <state>Florida</state>
        <zip>32081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Sanford</city>
        <state>Florida</state>
        <zip>32771</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60654</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Munster</city>
        <state>Indiana</state>
        <zip>46321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Auburn</city>
        <state>Maine</state>
        <zip>04210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <zip>02301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Marquette</city>
        <state>Michigan</state>
        <zip>49855</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Brooklyn Center</city>
        <state>Minnesota</state>
        <zip>55430</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cortlandt Manor</city>
        <state>New York</state>
        <zip>10567</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Endwell</city>
        <state>New York</state>
        <zip>13760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <zip>14221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44311</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cadiz</city>
        <state>Ohio</state>
        <zip>43907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Norman</city>
        <state>Oklahoma</state>
        <zip>73069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Duncansville</city>
        <state>Pennsylvania</state>
        <zip>16635</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <zip>37620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77002</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2015</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Maroubra</city>
        <state>New South Wales</state>
        <zip>2035</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2022</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Anthée</city>
        <zip>5520</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Gozee</city>
        <zip>6534</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Gribomont</city>
        <zip>6887</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Halen</city>
        <zip>3545</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ham</city>
        <zip>3945</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Linkebeek</city>
        <zip>1630</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ukkel</city>
        <zip>1180</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1Y 1V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Bay Roberts</city>
        <state>Newfoundland and Labrador</state>
        <zip>A0A 1G0</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Mount Pearl</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1N 1W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1A 3R5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 6V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N5W 6A2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 5G8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <zip>N7T 4X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3C 5K7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M8V 3X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M9V 4B4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M9W 4L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Woodstock</city>
        <state>Ontario</state>
        <zip>N4S 5P5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Chicoutimi</city>
        <state>Quebec</state>
        <zip>G7H 5H6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Gatineau</city>
        <state>Quebec</state>
        <zip>J8Y 6S9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Granby</city>
        <state>Quebec</state>
        <zip>J2G 8Z9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Lachine</city>
        <state>Quebec</state>
        <zip>H8S 2E4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Pointe-Claire</city>
        <state>Quebec</state>
        <zip>H9R 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4M6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Brno</city>
        <zip>601 77</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Brno</city>
        <zip>603 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Praha 2</city>
        <zip>120 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Praha 4</city>
        <zip>140 21</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Slany</city>
        <zip>274 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Svitavy</city>
        <zip>568 25</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Usti nad Orlici</city>
        <zip>562 18</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Znojmo</city>
        <zip>669 02</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ballerup</city>
        <zip>2750</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Vejle</city>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>OYS</city>
        <zip>90029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Köln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>New Territories</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Budapest</city>
        <zip>1096</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Dunaujvaros</city>
        <zip>2400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Gyula</city>
        <zip>5700</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kecskemet</city>
        <zip>6000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Komarom</city>
        <zip>2921</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Szolnok</city>
        <zip>5004</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Zalaegerszeg</city>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Nagoya-shi</city>
        <state>Aichi</state>
        <zip>454-0933</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Nagoya-shi</city>
        <state>Aichi</state>
        <zip>455-8530</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Nagoya-shi</city>
        <state>Aichi</state>
        <zip>462-0825</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Fukui-shi</city>
        <state>Fukui</state>
        <zip>910-0837</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kasuga-shi</city>
        <state>Fukuoka</state>
        <zip>816-0864</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Fujioka-shi</city>
        <state>Gunma</state>
        <zip>375-0015</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Maebashi-shi</city>
        <state>Gunma</state>
        <zip>371-0022</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Maebashi-shi</city>
        <state>Gunma</state>
        <zip>371-0046</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Takasaki-shi</city>
        <state>Gunma</state>
        <zip>370-0829</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kawanishi-shi</city>
        <state>Hyogo</state>
        <zip>666-0125</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kobe-shi</city>
        <state>Hyogo</state>
        <zip>657-0068</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Hitachi-shi</city>
        <state>Ibaraki</state>
        <zip>317-0077</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Koga-shi</city>
        <state>Ibaraki</state>
        <zip>306-0041</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Mito-shi</city>
        <state>Ibaraki</state>
        <zip>311-4198</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Komatsu-shi</city>
        <state>Ishikawa</state>
        <zip>923-8560</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Takamatsu-shi</city>
        <state>Kagawa</state>
        <zip>760-8557</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kochi-shi</city>
        <state>Kochi</state>
        <zip>781-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kyoto-shi</city>
        <state>Kyoto</state>
        <zip>613-0911</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kyoto-shi</city>
        <state>Kyoto</state>
        <zip>615-8125</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ina-shi</city>
        <state>Nagano</state>
        <zip>396-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Matsumoto-shi</city>
        <state>Nagano</state>
        <zip>390-0848</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Suwa-shi</city>
        <state>Nagano</state>
        <zip>392-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ibaraki-shi</city>
        <state>Osaka</state>
        <zip>567-0876</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Toyonaka-shi</city>
        <state>Osaka</state>
        <zip>560-0082</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Hanyu-shi</city>
        <state>Saitama</state>
        <zip>348-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Sayama-shi</city>
        <state>Saitama</state>
        <zip>350-1305</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Toda-shi</city>
        <state>Saitama</state>
        <zip>335-0023</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Chiyoda-ku</city>
        <state>Tokyo</state>
        <zip>101-0041</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Hachioji-shi</city>
        <state>Tokyo</state>
        <zip>192-0918</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Itabashi-ku</city>
        <state>Tokyo</state>
        <zip>173-8610</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Shinagawa-ku</city>
        <state>Tokyo</state>
        <zip>141-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Toshima-ku</city>
        <state>Tokyo</state>
        <zip>171-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Hoorn</city>
        <zip>1625 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Oslo</city>
        <zip>0373</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Johannesburg</city>
        <state>Gauteng</state>
        <zip>2193</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Midrand</city>
        <state>Gauteng</state>
        <zip>1685</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Observatory</city>
        <state>Western Cape</state>
        <zip>7925</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Parow</city>
        <state>Western Cape</state>
        <zip>7505</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Cordoba</city>
        <state>Andalucía</state>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Zaragoza</city>
        <state>Aragón</state>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Reus</city>
        <state>Cataluña</state>
        <zip>43204</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Göteborg</city>
        <zip>412 63</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Lund</city>
        <zip>222 21</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Stockholm</city>
        <zip>111 35</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>London</city>
        <zip>SW10 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>http://www.amgentrials.com</url>
    <description>AmgenTrials clinical trials website</description>
  </link>
  <reference>
    <citation>Koren MJ, Sabatine MS, Giugliano RP, Langslet G, Wiviott SD, Kassahun H, Ruzza A, Ma Y, Somaratne R, Raal FJ. Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study. JAMA Cardiol. 2017 Jun 1;2(6):598-607. doi: 10.1001/jamacardio.2017.0747.</citation>
    <PMID>28291870</PMID>
  </reference>
  <reference>
    <citation>Sattar N, Toth PP, Blom DJ, Koren MJ, Soran H, Uhart M, Elliott M, Cyrille M, Somaratne R, Preiss D. Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus. Am J Cardiol. 2017 Nov 1;120(9):1521-1527. doi: 10.1016/j.amjcard.2017.07.047. Epub 2017 Jul 31.</citation>
    <PMID>28844508</PMID>
  </reference>
  <reference>
    <citation>Kasichayanula S, Grover A, Emery MG, Gibbs MA, Somaratne R, Wasserman SM, Gibbs JP. Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor. Clin Pharmacokinet. 2018 Jul;57(7):769-779. doi: 10.1007/s40262-017-0620-7. Review.</citation>
    <PMID>29353350</PMID>
  </reference>
  <reference>
    <citation>Hovingh GK, Raal FJ, Dent R, Stefanutti C, Descamps O, Masana L, Lira A, Bridges I, Coll B, Sullivan D. Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia. J Clin Lipidol. 2017 Nov - Dec;11(6):1448-1457. doi: 10.1016/j.jacl.2017.09.003. Epub 2017 Sep 22.</citation>
    <PMID>29066265</PMID>
  </reference>
  <reference>
    <citation>Koren MJ, Giugliano RP, Raal FJ, Sullivan D, Bolognese M, Langslet G, Civeira F, Somaratne R, Nelson P, Liu T, Scott R, Wasserman SM, Sabatine MS; OSLER Investigators. Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. Circulation. 2014 Jan 14;129(2):234-43. doi: 10.1161/CIRCULATIONAHA.113.007012. Epub 2013 Nov 19.</citation>
    <PMID>24255061</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 22, 2011</study_first_submitted>
  <study_first_submitted_qc>September 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2011</study_first_posted>
  <results_first_submitted>June 17, 2019</results_first_submitted>
  <results_first_submitted_qc>June 17, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 10, 2019</results_first_posted>
  <last_update_submitted>June 17, 2019</last_update_submitted>
  <last_update_submitted_qc>June 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>High cholesterol</keyword>
  <keyword>Raised cholesterol</keyword>
  <keyword>Cholesterol</keyword>
  <keyword>Elevated Cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Evolocumab</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 12, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/80/NCT01439880/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/80/NCT01439880/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This extension study was conducted at 188 centers in 18 countries. Participants were enrolled from one of five eligible phase 2 parent studies: 20101154 (NCT01375777), 20101155 (NCT01380730), 20090158 (NCT01375751), 20090159 (NCT01375764), and 20110231 (NCT01652703).
Participants were enrolled from October 2011 to June 2013.</recruitment_details>
      <pre_assignment_details>Participants were randomized in a 2:1 ratio, irrespective of their treatment assignments during the phase 2 parent study, to either evolocumab plus standard of care (SOC) or SOC alone. Randomization was stratified by the treatment to which the participant was randomized to in the parent study, ie evolocumab or control.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Standard of Care</title>
          <description>Participants randomized to receive standard of care (SOC) treatment for the first year of the extension study (SOC-controlled period).
At week 52 participants began treatment with evolocumab 420 mg QM for up to 4 years in the all-investigational product [all-IP] period.</description>
        </group>
        <group group_id="P2">
          <title>Evolocumab + SOC</title>
          <description>Participants randomized to receive evolocumab 420 mg once a month plus standard of care for the first year of the extension study (SOC-controlled period).
At week 52 participants continued treatment with evolocumab 420 mg QM for up to 4 years in the all-IP period.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>SOC-controlled Period (Year 1)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="442"/>
                <participants group_id="P2" count="882"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received Evolocumab</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="881"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="398"/>
                <participants group_id="P2" count="822"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Sponsor Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Reason Missing</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>All-IP Period (Years 2 to 5)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="398"/>
                <participants group_id="P2" count="822"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received Evolocumab</title>
              <participants_list>
                <participants group_id="P1" count="374"/>
                <participants group_id="P2" count="777"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="328"/>
                <participants group_id="P2" count="682"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="140"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="66"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Sponsor Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Reason Missing</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The full analysis set included all randomized participants</population>
      <group_list>
        <group group_id="B1">
          <title>Standard of Care</title>
          <description>Participants randomized to receive standard of care (SOC) treatment for the first year of the extension study (SOC-controlled period).</description>
        </group>
        <group group_id="B2">
          <title>Evolocumab + SOC</title>
          <description>Participants randomized to receive evolocumab 420 mg once a month plus standard of care for the first year of the extension study (SOC-controlled period).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="442"/>
            <count group_id="B2" value="882"/>
            <count group_id="B3" value="1324"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.6" spread="11.5"/>
                    <measurement group_id="B2" value="56.9" spread="11.6"/>
                    <measurement group_id="B3" value="57.1" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt; 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="307"/>
                    <measurement group_id="B2" value="632"/>
                    <measurement group_id="B3" value="939"/>
                  </measurement_list>
                </category>
                <category>
                  <title>≥ 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="135"/>
                    <measurement group_id="B2" value="250"/>
                    <measurement group_id="B3" value="385"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="241"/>
                    <measurement group_id="B2" value="459"/>
                    <measurement group_id="B3" value="700"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="201"/>
                    <measurement group_id="B2" value="423"/>
                    <measurement group_id="B3" value="624"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="429"/>
                    <measurement group_id="B2" value="843"/>
                    <measurement group_id="B3" value="1272"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="168"/>
                    <measurement group_id="B3" value="255"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="325"/>
                    <measurement group_id="B2" value="648"/>
                    <measurement group_id="B3" value="973"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mixed Race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>North America</title>
                  <measurement_list>
                    <measurement group_id="B1" value="214"/>
                    <measurement group_id="B2" value="441"/>
                    <measurement group_id="B3" value="655"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Europe</title>
                  <measurement_list>
                    <measurement group_id="B1" value="133"/>
                    <measurement group_id="B2" value="261"/>
                    <measurement group_id="B3" value="394"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asia Pacific</title>
                  <measurement_list>
                    <measurement group_id="B1" value="95"/>
                    <measurement group_id="B2" value="180"/>
                    <measurement group_id="B3" value="275"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parent Study Baseline Low-density Lipoprotein Cholesterol (LDL-C) Concentration</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144.6" spread="37.4"/>
                    <measurement group_id="B2" value="139.7" spread="36.7"/>
                    <measurement group_id="B3" value="141.3" spread="37.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stratification Factor: Parent Study Treatment Assignment</title>
          <description>Randomization was stratified by the treatment to which a participant was randomized to in the parent study, according to the following:
randomized to evolocumab every 2 weeks (Q2W)
randomized to evolocumab QM
not randomized to evolocumab</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Evolocumab once monthly (QM)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="193"/>
                    <measurement group_id="B2" value="387"/>
                    <measurement group_id="B3" value="580"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Evolocumab every 2 weeks (Q2M)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="129"/>
                    <measurement group_id="B2" value="256"/>
                    <measurement group_id="B3" value="385"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No evolocumab</title>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                    <measurement group_id="B2" value="239"/>
                    <measurement group_id="B3" value="359"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Adverse Events</title>
        <description>Adverse event (AE) severity assessments were made using National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) grading, version 4.03, where grade 1 = mild AE, grade 2 = moderate AE, Grade 3 = severe AE, grade 4 = life-threatening AE and Grade 5 = death due to AE.</description>
        <time_frame>52 weeks in the SOC-controlled period and up to 4 years in the All-IP period; actual median duration of treatment in the All-IP period was 46.9 months.</time_frame>
        <population>All randomized participants (year 1) and randomized participants on study and who received at least 1 dose of evolocumab in the all-IP period (years 2-5).</population>
        <group_list>
          <group group_id="O1">
            <title>SOC-controlled Period: Standard of Care</title>
            <description>Participants randomized to receive standard of care (SOC) treatment for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O2">
            <title>SOC-controlled Period: Evolocumab + SOC</title>
            <description>Participants randomized to receive evolocumab 420 mg once a month plus standard of care for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O3">
            <title>All-IP Period: SOC / Evolocumab + SOC</title>
            <description>At week 52 participants began treatment with evolocumab 420 mg QM for up to 4 years during the all-IP period.</description>
          </group>
          <group group_id="O4">
            <title>All-IP Period: Evolocumab + SOC / Evolocumab + SOC</title>
            <description>At week 52 participants continued treatment with evolocumab 420 mg QM for another 4 years during the all-IP period.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adverse Events</title>
          <description>Adverse event (AE) severity assessments were made using National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) grading, version 4.03, where grade 1 = mild AE, grade 2 = moderate AE, Grade 3 = severe AE, grade 4 = life-threatening AE and Grade 5 = death due to AE.</description>
          <population>All randomized participants (year 1) and randomized participants on study and who received at least 1 dose of evolocumab in the all-IP period (years 2-5).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="882"/>
                <count group_id="O3" value="374"/>
                <count group_id="O4" value="777"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All adverse events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="327"/>
                    <measurement group_id="O2" value="728"/>
                    <measurement group_id="O3" value="342"/>
                    <measurement group_id="O4" value="718"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adverse events ≥ grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="99"/>
                    <measurement group_id="O3" value="111"/>
                    <measurement group_id="O4" value="229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adverse events ≥ grade 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious adverse events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="72"/>
                    <measurement group_id="O3" value="76"/>
                    <measurement group_id="O4" value="172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AEs leading to discontinuation of evolocumab</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatal adverse events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Low-density Lipoprotein Cholesterol (LDL-C) Level at Week 24 and Week 52</title>
        <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
        <population>Participants randomized in study 20110110 and with available data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care</title>
            <description>Participants randomized to receive standard of care (SOC) treatment for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O2">
            <title>Evolocumab + SOC</title>
            <description>Participants randomized to receive evolocumab 420 mg once a month plus standard of care for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O3">
            <title>Control in Parent Study: SOC</title>
            <description>Participants who received a control treatment in the parent study received standard of care treatment for the first year of the extension study.</description>
          </group>
          <group group_id="O4">
            <title>Control in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received a control treatment in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
          <group group_id="O5">
            <title>Evolocumab in Parent Study: SOC</title>
            <description>Participants who received evolocumab in the parent study received standard of care treatment during the first year of the extension study.</description>
          </group>
          <group group_id="O6">
            <title>Evolocumab in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received evolocumab in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
        </group_list>
        <measure>
          <title>Low-density Lipoprotein Cholesterol (LDL-C) Level at Week 24 and Week 52</title>
          <population>Participants randomized in study 20110110 and with available data at each time point.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="882"/>
                <count group_id="O3" value="120"/>
                <count group_id="O4" value="239"/>
                <count group_id="O5" value="322"/>
                <count group_id="O6" value="643"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Parent Study Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="442"/>
                    <count group_id="O2" value="882"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="239"/>
                    <count group_id="O5" value="322"/>
                    <count group_id="O6" value="643"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="144.6" spread="37.4"/>
                    <measurement group_id="O2" value="139.7" spread="36.7"/>
                    <measurement group_id="O3" value="147.7" spread="34.3"/>
                    <measurement group_id="O4" value="139.5" spread="33.6"/>
                    <measurement group_id="O5" value="143.4" spread="38.5"/>
                    <measurement group_id="O6" value="139.8" spread="37.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="416"/>
                    <count group_id="O2" value="852"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="232"/>
                    <count group_id="O5" value="303"/>
                    <count group_id="O6" value="620"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="136.9" spread="41.5"/>
                    <measurement group_id="O2" value="64.1" spread="33.3"/>
                    <measurement group_id="O3" value="142.5" spread="44.7"/>
                    <measurement group_id="O4" value="63.9" spread="34.6"/>
                    <measurement group_id="O5" value="134.8" spread="40.2"/>
                    <measurement group_id="O6" value="64.2" spread="32.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="399"/>
                    <count group_id="O2" value="826"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="224"/>
                    <count group_id="O5" value="286"/>
                    <count group_id="O6" value="602"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140.5" spread="40.0"/>
                    <measurement group_id="O2" value="65.0" spread="34.4"/>
                    <measurement group_id="O3" value="143.1" spread="39.8"/>
                    <measurement group_id="O4" value="64.1" spread="33.2"/>
                    <measurement group_id="O5" value="139.4" spread="40.1"/>
                    <measurement group_id="O6" value="65.3" spread="34.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non-high-density Lipoprotein Cholesterol (Non-HDL-C) Level at Week 24 and Week 52</title>
        <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
        <population>Participants randomized in the extension study 20110110 and with available data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care</title>
            <description>Participants randomized to receive standard of care (SOC) treatment for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O2">
            <title>Evolocumab + SOC</title>
            <description>Participants randomized to receive evolocumab 420 mg once a month plus standard of care for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O3">
            <title>Control in Parent Study: SOC</title>
            <description>Participants who received a control treatment in the parent study received standard of care treatment for the first year of the extension study.</description>
          </group>
          <group group_id="O4">
            <title>Control in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received a control treatment in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
          <group group_id="O5">
            <title>Evolocumab in Parent Study: SOC</title>
            <description>Participants who received evolocumab in the parent study received standard of care treatment during the first year of the extension study.</description>
          </group>
          <group group_id="O6">
            <title>Evolocumab in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received evolocumab in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
        </group_list>
        <measure>
          <title>Non-high-density Lipoprotein Cholesterol (Non-HDL-C) Level at Week 24 and Week 52</title>
          <population>Participants randomized in the extension study 20110110 and with available data at each time point.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="882"/>
                <count group_id="O3" value="120"/>
                <count group_id="O4" value="239"/>
                <count group_id="O5" value="322"/>
                <count group_id="O6" value="643"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Parent Study Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="442"/>
                    <count group_id="O2" value="882"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="239"/>
                    <count group_id="O5" value="322"/>
                    <count group_id="O6" value="643"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="170.7" spread="43.0"/>
                    <measurement group_id="O2" value="165.1" spread="40.9"/>
                    <measurement group_id="O3" value="173.8" spread="39.6"/>
                    <measurement group_id="O4" value="165.5" spread="38.9"/>
                    <measurement group_id="O5" value="169.6" spread="44.2"/>
                    <measurement group_id="O6" value="165.0" spread="41.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="416"/>
                    <count group_id="O2" value="852"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="232"/>
                    <count group_id="O5" value="303"/>
                    <count group_id="O6" value="620"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="161.4" spread="45.5"/>
                    <measurement group_id="O2" value="84.3" spread="37.7"/>
                    <measurement group_id="O3" value="166.9" spread="47.5"/>
                    <measurement group_id="O4" value="84.3" spread="39.0"/>
                    <measurement group_id="O5" value="159.4" spread="44.6"/>
                    <measurement group_id="O6" value="84.3" spread="37.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="399"/>
                    <count group_id="O2" value="825"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="224"/>
                    <count group_id="O5" value="286"/>
                    <count group_id="O6" value="601"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164.9" spread="44.5"/>
                    <measurement group_id="O2" value="85.3" spread="39.0"/>
                    <measurement group_id="O3" value="168.8" spread="45.3"/>
                    <measurement group_id="O4" value="85.0" spread="38.4"/>
                    <measurement group_id="O5" value="163.4" spread="44.1"/>
                    <measurement group_id="O6" value="85.4" spread="39.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apolipoprotein B Level at Week 24 and Week 52</title>
        <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
        <population>Participants randomized in the extension study 20110110 and with available data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care</title>
            <description>Participants randomized to receive standard of care (SOC) treatment for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O2">
            <title>Evolocumab + SOC</title>
            <description>Participants randomized to receive evolocumab 420 mg once a month plus standard of care for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O3">
            <title>Control in Parent Study: SOC</title>
            <description>Participants who received a control treatment in the parent study received standard of care treatment for the first year of the extension study.</description>
          </group>
          <group group_id="O4">
            <title>Control in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received a control treatment in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
          <group group_id="O5">
            <title>Evolocumab in Parent Study: SOC</title>
            <description>Participants who received evolocumab in the parent study received standard of care treatment during the first year of the extension study.</description>
          </group>
          <group group_id="O6">
            <title>Evolocumab in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received evolocumab in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
        </group_list>
        <measure>
          <title>Apolipoprotein B Level at Week 24 and Week 52</title>
          <population>Participants randomized in the extension study 20110110 and with available data at each time point.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="882"/>
                <count group_id="O3" value="120"/>
                <count group_id="O4" value="239"/>
                <count group_id="O5" value="322"/>
                <count group_id="O6" value="643"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Parent Study Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="442"/>
                    <count group_id="O2" value="882"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="239"/>
                    <count group_id="O5" value="322"/>
                    <count group_id="O6" value="643"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="113.2" spread="25.3"/>
                    <measurement group_id="O2" value="110.4" spread="23.8"/>
                    <measurement group_id="O3" value="115.4" spread="23.1"/>
                    <measurement group_id="O4" value="110.3" spread="22.4"/>
                    <measurement group_id="O5" value="112.4" spread="26.0"/>
                    <measurement group_id="O6" value="110.4" spread="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="416"/>
                    <count group_id="O2" value="852"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="232"/>
                    <count group_id="O5" value="303"/>
                    <count group_id="O6" value="620"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.9" spread="26.3"/>
                    <measurement group_id="O2" value="60.8" spread="23.3"/>
                    <measurement group_id="O3" value="110.5" spread="27.0"/>
                    <measurement group_id="O4" value="60.7" spread="23.9"/>
                    <measurement group_id="O5" value="106.9" spread="26.0"/>
                    <measurement group_id="O6" value="60.9" spread="23.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="401"/>
                    <count group_id="O2" value="834"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="227"/>
                    <count group_id="O5" value="288"/>
                    <count group_id="O6" value="607"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109.5" spread="26.8"/>
                    <measurement group_id="O2" value="61.6" spread="23.5"/>
                    <measurement group_id="O3" value="110.7" spread="26.3"/>
                    <measurement group_id="O4" value="61.7" spread="23.0"/>
                    <measurement group_id="O5" value="109.1" spread="27.0"/>
                    <measurement group_id="O6" value="61.6" spread="23.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Cholesterol/HDL-C Ratio at Week 24 and Week 52</title>
        <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
        <population>Participants randomized in the extension study 20110110 and with available data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care</title>
            <description>Participants randomized to receive standard of care (SOC) treatment for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O2">
            <title>Evolocumab + SOC</title>
            <description>Participants randomized to receive evolocumab 420 mg once a month plus standard of care for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O3">
            <title>Control in Parent Study: SOC</title>
            <description>Participants who received a control treatment in the parent study received standard of care treatment for the first year of the extension study.</description>
          </group>
          <group group_id="O4">
            <title>Control in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received a control treatment in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
          <group group_id="O5">
            <title>Evolocumab in Parent Study: SOC</title>
            <description>Participants who received evolocumab in the parent study received standard of care treatment during the first year of the extension study.</description>
          </group>
          <group group_id="O6">
            <title>Evolocumab in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received evolocumab in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Cholesterol/HDL-C Ratio at Week 24 and Week 52</title>
          <population>Participants randomized in the extension study 20110110 and with available data at each time point.</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="882"/>
                <count group_id="O3" value="120"/>
                <count group_id="O4" value="239"/>
                <count group_id="O5" value="322"/>
                <count group_id="O6" value="643"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Parent Study Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="442"/>
                    <count group_id="O2" value="882"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="239"/>
                    <count group_id="O5" value="322"/>
                    <count group_id="O6" value="643"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.516" spread="1.617"/>
                    <measurement group_id="O2" value="4.386" spread="1.393"/>
                    <measurement group_id="O3" value="4.458" spread="1.345"/>
                    <measurement group_id="O4" value="4.388" spread="1.340"/>
                    <measurement group_id="O5" value="4.538" spread="1.708"/>
                    <measurement group_id="O6" value="4.386" spread="1.413"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="416"/>
                    <count group_id="O2" value="852"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="232"/>
                    <count group_id="O5" value="303"/>
                    <count group_id="O6" value="620"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.198" spread="1.536"/>
                    <measurement group_id="O2" value="2.603" spread="0.978"/>
                    <measurement group_id="O3" value="4.192" spread="1.408"/>
                    <measurement group_id="O4" value="2.594" spread="0.970"/>
                    <measurement group_id="O5" value="4.201" spread="1.584"/>
                    <measurement group_id="O6" value="2.607" spread="0.982"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="399"/>
                    <count group_id="O2" value="825"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="224"/>
                    <count group_id="O5" value="286"/>
                    <count group_id="O6" value="601"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.277" spread="1.652"/>
                    <measurement group_id="O2" value="2.626" spread="1.025"/>
                    <measurement group_id="O3" value="4.252" spread="1.434"/>
                    <measurement group_id="O4" value="2.622" spread="1.033"/>
                    <measurement group_id="O5" value="4.286" spread="1.733"/>
                    <measurement group_id="O6" value="2.628" spread="1.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apolipoprotein B/Apolipoprotein A1 Ratio at Week 24 and Week 52</title>
        <time_frame>Baseline of parent study and extension study weeks 24 and 52</time_frame>
        <population>Participants randomized in the extension study 20110110 and with available data at each time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care</title>
            <description>Participants randomized to receive standard of care (SOC) treatment for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O2">
            <title>Evolocumab + SOC</title>
            <description>Participants randomized to receive evolocumab 420 mg once a month plus standard of care for the first year of the extension study (SOC-controlled period).</description>
          </group>
          <group group_id="O3">
            <title>Control in Parent Study: SOC</title>
            <description>Participants who received a control treatment in the parent study received standard of care treatment for the first year of the extension study.</description>
          </group>
          <group group_id="O4">
            <title>Control in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received a control treatment in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
          <group group_id="O5">
            <title>Evolocumab in Parent Study: SOC</title>
            <description>Participants who received evolocumab in the parent study received standard of care treatment during the first year of the extension study.</description>
          </group>
          <group group_id="O6">
            <title>Evolocumab in Parent Study: Evolocumab + SOC</title>
            <description>Participants who received evolocumab in the parent study received subcutaneous evolocumab 420 mg QM plus standard of care during the first year of the extension study.</description>
          </group>
        </group_list>
        <measure>
          <title>Apolipoprotein B/Apolipoprotein A1 Ratio at Week 24 and Week 52</title>
          <population>Participants randomized in the extension study 20110110 and with available data at each time point.</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="882"/>
                <count group_id="O3" value="120"/>
                <count group_id="O4" value="239"/>
                <count group_id="O5" value="322"/>
                <count group_id="O6" value="643"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Parent Study Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="442"/>
                    <count group_id="O2" value="882"/>
                    <count group_id="O3" value="120"/>
                    <count group_id="O4" value="239"/>
                    <count group_id="O5" value="322"/>
                    <count group_id="O6" value="643"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.759" spread="0.237"/>
                    <measurement group_id="O2" value="0.739" spread="0.217"/>
                    <measurement group_id="O3" value="0.764" spread="0.201"/>
                    <measurement group_id="O4" value="0.735" spread="0.212"/>
                    <measurement group_id="O5" value="0.757" spread="0.249"/>
                    <measurement group_id="O6" value="0.741" spread="0.218"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="416"/>
                    <count group_id="O2" value="852"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="232"/>
                    <count group_id="O5" value="303"/>
                    <count group_id="O6" value="620"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.717" spread="0.242"/>
                    <measurement group_id="O2" value="0.386" spread="0.178"/>
                    <measurement group_id="O3" value="0.715" spread="0.222"/>
                    <measurement group_id="O4" value="0.385" spread="0.183"/>
                    <measurement group_id="O5" value="0.718" spread="0.250"/>
                    <measurement group_id="O6" value="0.387" spread="0.176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="401"/>
                    <count group_id="O2" value="834"/>
                    <count group_id="O3" value="113"/>
                    <count group_id="O4" value="227"/>
                    <count group_id="O5" value="288"/>
                    <count group_id="O6" value="607"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.726" spread="0.256"/>
                    <measurement group_id="O2" value="0.394" spread="0.185"/>
                    <measurement group_id="O3" value="0.719" spread="0.216"/>
                    <measurement group_id="O4" value="0.393" spread="0.186"/>
                    <measurement group_id="O5" value="0.729" spread="0.271"/>
                    <measurement group_id="O6" value="0.394" spread="0.185"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>52 weeks in the SOC-controlled period and up to 4 years in the All-IP period; median duration of treatment in the All-IP period was 46.9 months.</time_frame>
      <desc>Adverse events are reported for all randomized participants in the SOC-controlled period (year 1) and for all participants who entered the All-IP period (years 2-5).
Other Adverse Events summarizes the non-serious occurrences of adverse events that exceed the indicated frequency threshold.</desc>
      <group_list>
        <group group_id="E1">
          <title>SOC-controlled Period: SOC</title>
          <description>Participants received standard of care (SOC) treatment for the first year of the study (SOC-controlled period).</description>
        </group>
        <group group_id="E2">
          <title>SOC-controlled Period: Evolocumab + SOC</title>
          <description>Participants received evolocumab 420 mg once a month for the first year of the study (SOC-controlled period).</description>
        </group>
        <group group_id="E3">
          <title>All-IP Period: SOC / Evolocumab</title>
          <description>At week 52 participants began treatment with evolocumab 420 mg QM for up to 4 years during the all-IP period.</description>
        </group>
        <group group_id="E4">
          <title>All-IP Period: Evolocumab + SOC / Evolocumab</title>
          <description>At week 52 participants continued treatment with evolocumab 420 mg QM for another 4 years during the all-IP period.</description>
        </group>
        <group group_id="E5">
          <title>All-IP Period: Total</title>
          <description>All participants in the All-IP period who received evolocumab 420 mg QM for up to 4 years.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="72" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="78" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="181" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="259" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Aortic valve disease mixed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Aortic valve sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Coronary artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Mitral valve disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Mitral valve disease mixed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Nodal rhythm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Thyroiditis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cataract cortical</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Corneal defect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Brunner's gland hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Lumbar hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Obstructive pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Oesophageal spasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Splenic artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Tooth impacted</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Nodule</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Organ failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Autoimmune hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hepatotoxicity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Contrast media allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Appendiceal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bacterial pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bursitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Gastroenteritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Infective spondylitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Joint abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Ophthalmic herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Rocky mountain spotted fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Anaesthetic complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cardiac contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Intervertebral disc injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Procedural nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Procedural vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pulmonary contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Electrocardiogram ST segment abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>HIV test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Chondrocalcinosis pyrophosphate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Chondropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Adenoma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Anal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hairy cell leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Intraductal papilloma of breast</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Kaposi's sarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Mantle cell lymphoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Myxoid liposarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Thyroid adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Brain stem haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cerebral thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Facial paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Motor neurone disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Ectopic pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Bladder prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Laryngeal polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pharyngeal oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pulmonary granuloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Sinus polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Vocal cord polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Medical device removal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="217" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="513" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="311" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="626" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="937" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="33" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="61" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="94" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="32" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="52" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="32" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="55" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="43" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="59" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="40" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="94" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="134" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="39" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="64" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="47" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="81" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="128" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="64" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="148" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="122" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="236" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="358" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="68" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="99" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="72" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="57" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="118" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="175" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="35" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="60" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="43" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="63" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="109" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="172" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="51" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="117" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="168" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="39" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="60" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="62" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="81" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="54" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="81" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="44" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="32" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="70" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="102" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="51" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="71" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="54" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="44" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="72" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="40" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="77" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="117" subjects_at_risk="1220"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="42" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="56" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="442"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="882"/>
                <counts group_id="E3" subjects_affected="40" subjects_at_risk="398"/>
                <counts group_id="E4" subjects_affected="99" subjects_at_risk="822"/>
                <counts group_id="E5" subjects_affected="139" subjects_at_risk="1220"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Amgen Inc.</organization>
      <phone>866-572-6436</phone>
      <email>medinfo@amgen.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

